DRUG DISCOVERY FEATURED ARTICLES & APPLICATIONS

  • CDMOs — At The Core Of Next-Generation Pharma Models

    In today’s pharmaceutical industry, the economic strains of keeping a company completely vertically integrated are no longer feasible. Smaller, virtual drug companies simply do not have the resources necessary to translate a molecule to a drug product.

     

  • Streamlining Recombinant Protein Production

    Use of recombinant proteins as therapeutics has become an attractive strategy for altering the biology of disease progression and offers significant commercial opportunities.  However, bringing a recombinant protein to market requires a substantial investment of time and resources, and the process is generally complex and subject to technical pitfalls.

  • A Cure For Pharmaceutical Supply Chain Complexity

    The pharmaceutical industry lags in the sophistication and performance of its supply chains when they are compared with best-in-class companies in other industries. This is due to the complexity that has come with new drugs, more complex production technologies and evolving regulatory requirements. In this environment, integrating and aligning the supply chain makes it more flexible, bolstering operational performance and financial competitiveness.

  • Best Practices In Supply Chain Management: A CMO Perspective

    Supply chain management has advanced rapidly over the past decade, evolving from what was once dubbed “materials management” into the essential glue that binds all aspects of a business’ internal and external collaborations.

More From Featured Articles

LATEST NEWS

  • Grace Sells Chromatography Instruments, Columns, And Related Laboratory Product Lines

    W. R. Grace & Co. recently affirmed its commitment to three growing service lines for the pharmaceutical and nutraceutical industries, and announced agreements to sell product lines associated with its chromatography instruments, columns, and related laboratory products businesses that are not aligned with the company’s plans for growth.

More....

FEATURED PRODUCTS AND SERVICES

High Throughput Screens
CytoDynamix Screens are high throughput screens that are designed for tubulin ligants, which treat established tumors and metastatic cancer...
Plate Reader Plate Reader
Wallac ViewLux is a new plate reader for high throughput screening and drug discovery that accepts any object with
Drug Substance Manufacturing Drug Substance Manufacturing

Althea’s focused expertise and capabilities in current Good Manufacturing Practices (cGMP) production of microbial-based biotherapeutics make us one of the industry’s leaders in microbial fermentation. We offer a broad range of microbial-based cGMP biologics manufacturing services to biopharmaceutical companies worldwide. Althea is a recognized leader in plasmid DNA manufacturing for vaccines and gene therapy products. Althea has demonstrated experience in developing and manufacturing nearly 300 cGMP lots of bulk drug substance and has an impeccable regulatory track record. Our comprehensive, validated equipment has been utilized to fulfill numerous drug substance projects for preclinical and clinical supply. For additional information about Althea’s drug substance manufacturing services including contract cGMP microbial fermentation and biologics manufacturing, please contact us.

DNA Purification Systems DNA Purification Systems
Unlike other DNA purification systems requiring expensive filtration operations or time-consuming manual transfers to a centrifuge, RevolutionPrep (RevPrep) isolates plasmid DNA in 30 minutes, at a fraction of the cost of other automated systems.
Index Table Top Index Table Top
The New Index Table Top allows the use of different sizes and shapes of reagent containers from various suppliers
Fritsch P-7 Planetary Micro Mill Fritsch P-7 Planetary Micro Mill
Fritsch Planetary Mills rapidly grind materials to colloidal fineness of 1 µm and below by developing high grinding energy via planetary actions...
More Featured Products

INDUSTRY EVENTS

IVT’s 3rd Annual Microbiology Week June 7 - 9, 2016
Philadelphia, PA
FDA's New Guidance on Comparability Protocols: What You Need to Know June 7, 2016
1pm-2:30pm EDT, Online Training
Adverse Event Reporting: Avoiding Common Pitfalls June 8, 2016
1pm-2:30pm EDT, Online Training
Best Practices in CMC Dossier Preparation – Facing Tough Challenges June 9, 2016
Special Time for EU and US Participants - 10:30am-12pm EDT, Online Training
More Events....

 UPCOMING TRAINING COURSES

FDA's New Guidance on Comparability Protocols: What You Need to Know June 7, 2016
1pm-2:30pm EDT, Online Training
Adverse Event Reporting: Avoiding Common Pitfalls June 8, 2016
1pm-2:30pm EDT, Online Training
Best Practices in CMC Dossier Preparation – Facing Tough Challenges June 9, 2016
Special Time for EU and US Participants - 10:30am-12pm EDT, Online Training
More Upcoming Courses

PREMIER SERVICE PROVIDER